Boston Scientific To Release Broad Range Of Clinical Trial Data Reinforcing Safety And Efficacy Of Taxus(R) Coronary Stent Systems At TCT 2007

Boston Scientific Corporation (NYSE: BSX) announced the schedule of the Company’s major events and press announcements at the Cardiovascular Research Foundation’s (CRF) nineteenth annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, which runs from October 20 to 25 in Washington, D.C. [click link for full article]

More: continued here

Filed under: Cardiovascular on October 20th, 2007